10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2016 | |||
CONSOLIDATED STATEMENTS OF EARNINGS | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 21, 2017) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Net product sales | $ 17,702 | 14,045 | 11,660 |
| Alliance and other revenues | 1,725 | 2,515 | 4,219 |
| Total Revenues | 19,427 | 16,560 | 15,879 |
| Cost of products sold | 4,946 | 3,909 | 3,932 |
| Marketing, selling and administrative | 4,911 | 4,841 | 4,822 |
| Research and development | 4,940 | 5,920 | 4,534 |
| Other (income)/expense | (1,285) | (187) | 210 |
| Total Expenses | 13,512 | 14,483 | 13,498 |
| Earnings Before Income Taxes | 5,915 | 2,077 | 2,381 |
| Provision for Income Taxes | 1,408 | 446 | 352 |
| Net Earnings | 4,507 | 1,631 | 2,029 |
| Net Earnings Attributable to Noncontrolling Interest | 50 | 66 | 25 |
| Net Earnings Attributable to BMS | 4,457 | 1,565 | 2,004 |
| Earnings per Common Share | |||
| Basic Earnings Per Common Share Attributable to BMS | 2.67 | 0.94 | 1.21 |
| Diluted Earnings per Common Share Attributable to BMS | 2.65 | 0.93 | 1.20 |
| Cash dividends declared per common share | 1.53 | 1.49 | 1.45 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2016 | |||
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 21, 2017) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract] | |||
| Net Earnings | $ 4,507 | 1,631 | 2,029 |
| Other Comprehensive Income (Loss), net of taxes and reclassifications to earnings [Abstract] | |||
| Derivatives qualifying as cash flow hedges | 4 | (51) | 69 |
| Pension and postretirement benefits | (17) | 101 | (324) |
| Available-for-sale securities | 16 | (54) | 3 |
| Foreign currency translation | (38) | (39) | (32) |
| Total Other Comprehensive Income/(Loss) | (35) | (43) | (284) |
| Comprehensive Income | 4,472 | 1,588 | 1,745 |
| Comprehensive Income Attributable to Noncontrolling Interest | 50 | 66 | 25 |
| Comprehensive Income Attributable to BMS | 4,422 | 1,522 | 1,720 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2016 | |||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 21, 2017) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Cash Flows From Operating Activities: | |||
| Net Earnings | $ 4,507 | 1,631 | 2,029 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||
| Depreciation and amortization, net | 382 | 376 | 467 |
| Deferred income taxes | (204) | (347) | (542) |
| Stock-based compensation | 205 | 235 | 213 |
| Impairment charges | 108 | 192 | 401 |
| Pension settlements and amortization | 169 | 245 | 971 |
| Divestiture gains and royalties | (1,187) | (490) | (760) |
| Asset acquisition charge | 274 | 983 | 148 |
| Other adjustments | (44) | 15 | (21) |
| Changes in operating assets and liabilities: | |||
| Receivables | (803) | (942) | (252) |
| Inventories | (152) | 97 | (254) |
| Accounts payable | 104 | (919) | (44) |
| Deferred income | (64) | 218 | 613 |
| Income taxes payable | (545) | 47 | 171 |
| Other | 100 | 491 | 8 |
| Net Cash Provided by Operating Activities | 2,850 | 1,832 | 3,148 |
| Cash Flows From Investing Activities: | |||
| Sale and maturities of marketable securities | 4,809 | 2,794 | 4,095 |
| Purchase of marketable securities | (3,089) | (3,143) | (5,719) |
| Capital expenditures | (1,215) | (820) | (526) |
| Divestiture and other proceeds | 1,334 | 708 | 3,585 |
| Acquisition and other payments | (359) | (1,111) | (219) |
| Net Cash Provided by/(Used in) Investing Activities | 1,480 | (1,572) | 1,216 |
| Cash Flows From Financing Activities: | |||
| Short-term borrowings, net | 125 | (449) | 244 |
| Issuance of long-term debt | 1,268 | ||
| Repayment of long-term debt | (15) | (1,957) | (676) |
| Interest rate swap contract terminations | 42 | (2) | 105 |
| Issuance of common stock | 181 | 266 | 288 |
| Repurchase of common stock | (231) | ||
| Dividends | (2,547) | (2,477) | (2,398) |
| Net Cash Used in Financing Activities | (2,445) | (3,351) | (2,437) |
| Effect of Exchange Rates on Cash and Cash Equivalents | (33) | (95) | 58 |
| Increase/(Decrease) in Cash and Cash Equivalents | 1,852 | (3,186) | 1,985 |
| Cash and Cash Equivalents at Beginning of Year | 2,385 | 5,571 | |
| Cash and Cash Equivalents at End of Year | 4,237 | 2,385 | 5,571 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
BRISTOL MYERS SQUIBB CO | ||
Ticker: BMY Fiscal Year: 2016 | ||
CONSOLIDATED BALANCE SHEETS | ||
Period Ending Dec 31, 2016 10-K (Filed: Feb 21, 2017) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2016 | Dec 31, 2015 | |
| ASSETS | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 4,237 | 2,385 |
| Marketable securities, current | 2,113 | 1,885 |
| Receivables | 5,543 | 4,299 |
| Inventories | 1,241 | 1,221 |
| Prepaid expenses and other | 570 | 625 |
| Total Current Assets | 13,704 | 10,415 |
| Property, plant and equipment | 4,980 | 4,412 |
| Goodwill | 6,875 | 6,881 |
| Other intangible assets | 1,385 | 1,419 |
| Deferred income taxes | 2,996 | 2,844 |
| Marketable securities, noncurrent | 2,719 | 4,660 |
| Other assets | 1,048 | 1,117 |
| Total Assets | 33,707 | 31,748 |
| LIABILITIES | ||
| Current Liabilities: | ||
| Short-term borrowings and current portion of long-term debt | 992 | 139 |
| Accounts payable | 1,664 | 1,565 |
| Accrued liabilities | 5,271 | 4,738 |
| Deferred income, current | 762 | 1,003 |
| Income taxes payable, current | 152 | 572 |
| Total Current Liabilities | 8,841 | 8,017 |
| Deferred income, noncurrent | 547 | 586 |
| Income taxes payable, noncurrent | 973 | 742 |
| Pension and other liabilities | 1,283 | 1,429 |
| Long-term debt | 5,716 | 6,550 |
| Total Liabilities | 17,360 | 17,324 |
| Commitments and contingencies (Note 18) | ||
| EQUITY | ||
| Bristol-Myers Squibb Company Shareholders' Equity: | ||
| Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 4,129 in 2016 and 4,161 in 2015, liquidation value of $50 per share | 0 | 0 |
| Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.2 billion issued in both 2016 and 2015 | 221 | 221 |
| Capital in excess of par value of stock | 1,725 | 1,459 |
| Accumulated other comprehensive loss | (2,503) | (2,468) |
| Retained earnings | 33,513 | 31,613 |
| Less cost of treasury stock - 536 million common shares in 2016 and 539 million in 2015 | (16,779) | (16,559) |
| Total Bristol-Myers Squibb Company Shareholders' Equity | 16,177 | 14,266 |
| Noncontrolling interest | 170 | 158 |
| Total Equity | 16,347 | 14,424 |
| Total Liabilities and Equity | 33,707 | 31,748 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2016 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |